<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/elvn" ></link>
<id>urn:uuid:42be4a58-966d-1580-38fc-1872d4cb779f</id>
<updated>2026-05-03T21:40:53-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ELVN: COLLINS HELEN LOUISE (O) Exercised 5k Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 4/17, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6389231" ></link>
<id>urn:uuid:94d654f9-4662-7ece-214b-74ff1dff52b0</id>
<updated>2026-04-21T20:40:17-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $41.17. Mkt Cap:2.5B. 10D Vol: 777,220]]></summary>
</entry>
<entry>
<title>ELVN: COLLINS HELEN LOUISE (O) Exercised 40k Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 3/25, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6375023" ></link>
<id>urn:uuid:615b3471-dece-7935-a1cc-c230b0866975</id>
<updated>2026-03-27T16:57:22-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $41.17. Mkt Cap:2.5B. 10D Vol: 777,220]]></summary>
</entry>
<entry>
<title>ELVN: COLLINS HELEN LOUISE (O) Exercised 5k Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 3/17, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6370077" ></link>
<id>urn:uuid:6e3cac89-3cfb-ba86-dcb4-ad4e989a9de1</id>
<updated>2026-03-19T17:50:52-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $41.17. Mkt Cap:2.5B. 10D Vol: 777,220]]></summary>
</entry>
<entry>
<title>ELVN: COLLINS HELEN LOUISE (O) Exercised 40k Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 3/9-3/10, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6359358" ></link>
<id>urn:uuid:ea14eb3f-f2cd-0d1b-61fb-146f4df3dea3</id>
<updated>2026-03-11T17:32:25-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $41.17. Mkt Cap:2.5B. 10D Vol: 777,220]]></summary>
</entry>
<entry>
<title>ELVN: HOHL BENJAMIN (CFO) Sold (S) 10k Shares of ENLIVEN THERAPEUTICS INC for $29.58 on 3/6</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6357976" ></link>
<id>urn:uuid:24d9f787-30a4-441c-cf86-8cbc4c8d6be2</id>
<updated>2026-03-10T18:15:22-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $41.17. Mkt Cap:2.5B. 10D Vol: 777,220]]></summary>
</entry>
<entry>
<title>ELVN: HEYMAN RICHARD A (DIR) Sold (AS) 1,230 Shares of ENLIVEN THERAPEUTICS INC for $26.18 on 2/17</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6334268" ></link>
<id>urn:uuid:314a8026-14e0-7839-ecfc-2974b1681e60</id>
<updated>2026-02-19T18:38:29-05:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $41.17. Mkt Cap:2.5B. 10D Vol: 777,220]]></summary>
</entry>
</feed>